SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-046446
Filing Date
2019-12-20
Accepted
2019-12-20 07:14:25
Documents
10
Period of Report
2019-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-8k_20191220.htm 8-K 100059
2 EX-99.1 tcon-ex991_6.htm EX-99.1 35433
3 GRAPHIC giwb30gplruv000002.jpg GRAPHIC 16990
4 GRAPHIC giwb30gplruv000007.jpg GRAPHIC 13021
5 GRAPHIC giwb30gplruv000005.jpg GRAPHIC 16695
6 GRAPHIC giwb30gplruv000001.jpg GRAPHIC 28988
7 GRAPHIC giwb30gplruv000006.jpg GRAPHIC 12499
8 GRAPHIC giwb30gplruv000003.jpg GRAPHIC 13727
9 GRAPHIC giwb30gplruv000004.jpg GRAPHIC 20571
10 GRAPHIC gkmjyxol4o0q000001.jpg GRAPHIC 12142
  Complete submission text file 0001564590-19-046446.txt   323426
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 191297641
SIC: 2836 Biological Products, (No Diagnostic Substances)